These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 21605202)
21. Acute hemolysis of transfused A2 red cells by an auto-HI antibody. Darabi K; Makar RS Transfusion; 2008 May; 48(5):964-8. PubMed ID: 18454737 [TBL] [Abstract][Full Text] [Related]
22. Severe hemolytic anemia post-renal transplantation produced by donor anti-D passenger lymphocytes: case report and literature review. Ainsworth CD; Crowther MA; Treleaven D; Evanovitch D; Webert KE; Blajchman MA Transfus Med Rev; 2009 Apr; 23(2):155-9. PubMed ID: 19304116 [TBL] [Abstract][Full Text] [Related]
23. Autoantibody formation after alloimmunization inducing bystander immune hemolysis. Mota M; Bley C; Aravechia MG; Hamerschlak N; Sakashita A; Kutner JM; Castiho L Immunohematology; 2009; 25(1):9-12. PubMed ID: 19856726 [TBL] [Abstract][Full Text] [Related]
24. International collaborative study to evaluate candidate reference reagents to standardize haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulin products. Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW Vox Sang; 2009 Aug; 97(2):160-8. PubMed ID: 19402856 [TBL] [Abstract][Full Text] [Related]
25. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Natukunda B; Schonewille H; van de Watering L; Brand A Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889 [TBL] [Abstract][Full Text] [Related]
27. Anti-T haemolysins: the effects of sialic acid removal and 2-aminoethylisothiouronium bromide treatment of erythrocytes on immune lysis. des Roziers NB; Bodivit G; Chadebech P; Nzouakou R; Bierling P; Noizat-Pirenne F Vox Sang; 2011 May; 100(4):401-8. PubMed ID: 21118267 [TBL] [Abstract][Full Text] [Related]
28. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women]. Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952 [TBL] [Abstract][Full Text] [Related]
29. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience. Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802 [TBL] [Abstract][Full Text] [Related]
30. Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome. Chamouni P; Tamion F; Gueit I; Girault C; Lenain P; Varin R; Czernichow P Transfus Apher Sci; 2003 Apr; 28(2):117-24. PubMed ID: 12679114 [TBL] [Abstract][Full Text] [Related]
31. Severe immune haemolysis in a group A recipient of a group O red blood cell unit. Barjas-Castro ML; Locatelli MF; Carvalho MA; Gilli SO; Castro V Transfus Med; 2003 Aug; 13(4):239-41. PubMed ID: 12880395 [TBL] [Abstract][Full Text] [Related]
33. Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature. Desborough MJ; Miller J; Thorpe SJ; Murphy MF; Misbah SA Transfus Med; 2014 Aug; 24(4):219-26. PubMed ID: 24164446 [TBL] [Abstract][Full Text] [Related]
34. Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method. Stussi G; Huggel K; Lutz HU; Schanz U; Rieben R; Seebach JD Br J Haematol; 2005 Sep; 130(6):954-63. PubMed ID: 16156865 [TBL] [Abstract][Full Text] [Related]
35. International collaborative study to establish reference preparations to standardise haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulins by the direct method. Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):39-50. PubMed ID: 20223189 [TBL] [Abstract][Full Text] [Related]
36. [Severe hemolytic anemia caused by anti-AB in renal transplantation with minor ABO incompatibility]. Ríos Rull P; Rodríguez Pérez A; Ibáñez García A; Arrieta R; De la Cámara C Sangre (Barc); 1992 Jun; 37(3):197-9. PubMed ID: 1440097 [TBL] [Abstract][Full Text] [Related]
37. The role of inflammation in intravenous immune globulin-mediated hemolysis. Pendergrast J; Willie-Ramharack K; Sampson L; Laroche V; Branch DR Transfusion; 2015 Jul; 55 Suppl 2():S65-73. PubMed ID: 26174900 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. Jordan SC; Tyan D; Stablein D; McIntosh M; Rose S; Vo A; Toyoda M; Davis C; Shapiro R; Adey D; Milliner D; Graff R; Steiner R; Ciancio G; Sahney S; Light J J Am Soc Nephrol; 2004 Dec; 15(12):3256-62. PubMed ID: 15579530 [TBL] [Abstract][Full Text] [Related]
39. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810 [TBL] [Abstract][Full Text] [Related]
40. Intravenous immunoglobulin given to lymphoma patients with recurrent haemolytic transfusion reactions after transfusion of compatible blood. Win N; Madan B; Gale R; Matthey F Hematology; 2005 Oct; 10(5):375-8. PubMed ID: 16273724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]